5-Amino-1MQ
NNMT inhibitor — metabolic research. Limited human data; tracking framework for the available signals.
- Half-life
- Not established
- Out of system
- —
- Route
- Oral
- Level
- Intermediate
What 5-Amino-1MQ is used for
- NNMT inhibitor — metabolic + fat-loss research
- Oral, early but interesting mechanism
How it's typically used
Research range: 50–150 mg oral daily.
What to watch for
- Limited human data
- No established long-term safety
- Research-only; experimental
About Longevity
- What they are
- Compounds studied for cellular ageing — mitochondrial function, senescent-cell clearance, telomere and autophagy pathways.
- How they're run
- Mixed routes: some injected in short annual or biannual courses, others taken orally every day.
- What to watch
- Endpoints here are measured in decades, so nobody has human outcome data. Bloodwork and function markers are the only feedback you will get in a realistic timeframe.
Full guide
5-Amino-1MQ: A Tracking Guide for an NNMT Inhibitor
What 5-Amino-1MQ is, why it is studied as a metabolic compound, and how a self-experimenter can structure tracking around very limited human data.
Other longevity
Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.